MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

antibodies

  • Understanding Antibody Levels
    Understanding Antibody Levels
    Antibody levels don’t necessarily determine autoimmune severity.
    May 15, 2024BY Datis Kharrazian
  • Hidden Food Sensitivities May Boost Heart Disease Risk: Study
    Hidden Food Sensitivities May Boost Heart Disease Risk: Study
    Undetected food reactions could be secretly heightening your heart disease risk.
    November 17, 2023BY Sheramy Tsai
  • COVID-19 Oral Vaccine Pill Developed
    COVID-19 Oral Vaccine Pill Developed
    Researchers in Japan have discovered a way to administer the vaccine by mouth and in pill form instead ...
    September 16, 2023BY Mary Gillis
  • Vaccine Antibodies Can Be Transmitted Through Aerosols to Unvaccinated: Study | Facts Matter
    Vaccine Antibodies Can Be Transmitted Through Aerosols to Unvaccinated: Study | Facts Matter
    In a shocking development, a new peer-reviewed study found that people vaccinated with the mRNA-based COVID vaccines can ...
    August 7, 2023BY Roman Balmakov
  • Dr. Mobeen Syed: Pandemic Destruction and the Emergence of Anti-Antibodies
    Dr. Mobeen Syed: Pandemic Destruction and the Emergence of Anti-Antibodies
    During the COVID-19 pandemic, Dr. Mobeen Syed, also known as DrBeen, noticed there was a lack of unbiased, ...
    July 6, 2023BY Jan Jekielek
  • Study Reveals Remarkable Reversal of Previously Incurable Heart Failure Condition
    Study Reveals Remarkable Reversal of Previously Incurable Heart Failure Condition
    In a groundbreaking development, a recent study revealed that three men have successfully reversed their previously incurable heart ...
    June 18, 2023BY Jessie Zhang
  • Eggs May Hold the Key to a New COVID-19 Treatment
    Eggs May Hold the Key to a New COVID-19 Treatment
    Multiple studies published in the last two years indicate that eggs from chickens immunized against SARS-CoV-2 could be ...
    February 7, 2023BY David Charbonneau
  • Eli Lilly to Make COVID-19 Antibody Drug Commercially Available From August
    Eli Lilly to Make COVID-19 Antibody Drug Commercially Available From August
    Eli Lilly and Co. said on Wednesday it plans to make its COVID-19 antibody drug commercially available to ...
    August 5, 2022BY Reuters
  • AstraZeneca’s Imfinzi Fails Main Goal in Advanced Cervical Cancer Study
    AstraZeneca’s Imfinzi Fails Main Goal in Advanced Cervical Cancer Study
    AstraZeneca said on Thursday its drug Imfinzi, along with chemoradiotherapy, failed to achieve the main goal of improving ...
    March 25, 2022BY Reuters
  • 9 in 10 Young Teens in UK Likely to Have CCP Virus Antibodies: ONS Analysis
    9 in 10 Young Teens in UK Likely to Have CCP Virus Antibodies: ONS Analysis
    At the beginning of January, around 9 in 10 young teenagers in the UK had either previously had ...
    January 26, 2022BY Lily Zhou
  • What Is Original Antigenic Sin and Why Do We Care?
    What Is Original Antigenic Sin and Why Do We Care?
    Commentary As the United States feverishly rolls out COVID-19 vaccination “booster” shots, Israel is reporting trudging toward a ...
    January 20, 2022BY Todd J. Zywicki
  • Global License Deal Will ‘Turn the Tide’ on Pandemic, WHO Says
    Global License Deal Will ‘Turn the Tide’ on Pandemic, WHO Says
    The World Health Organization (WHO) on Tuesday said it has finalized a global license deal to ramp up ...
    November 23, 2021BY Isabel van Brugen
  • AstraZeneca Says Drug Cocktail Effective Against COVID-19 in Late-Stage Study
    AstraZeneca Says Drug Cocktail Effective Against COVID-19 in Late-Stage Study
    European drugmaker AstraZeneca this week said a late-stage study showed its antibody drug cocktail is effective at keeping COVID-19 ...
    October 12, 2021BY Zachary Stieber
  • Facts Matter (Oct. 4): Natural Antibodies Persist for More Than a Year After Infection: New Peer-Reviewed Study Finds
    Facts Matter (Oct. 4): Natural Antibodies Persist for More Than a Year After Infection: New Peer-Reviewed Study Finds
    A new peer-reviewed study, which came out of Europe, found that the vast majority of people who’ve had ...
    October 4, 2021BY Roman Balmakov
  • Antibodies Persist for More Than a Year After COVID-19 Infection, Study Finds
    Antibodies Persist for More Than a Year After COVID-19 Infection, Study Finds
    The immune systems of the vast majority of people who have been infected with the CCP virus will ...
    October 3, 2021BY Ivan Pentchoukov
  • Vaccine Antibodies Decline 7 Months After Second Pfizer Shot: US Study
    Vaccine Antibodies Decline 7 Months After Second Pfizer Shot: US Study
    Antibody levels generated by two shots of the Pfizer-BioNTech vaccine can undergo up to a 10-fold decrease seven ...
    October 3, 2021BY Tammy Hung
  • Alberta Evaluating Natural Immunity for Vaccine Passport Program
    Alberta Evaluating Natural Immunity for Vaccine Passport Program
    The Alberta government is looking into whether people with natural immunity against COVID-19 can qualify for its new ...
    September 20, 2021BY Isaac Teo
  • New Jersey Lawmaker to Propose Bill to Treat Recovered COVID-19 Patients No Different Than Vaccinated People
    New Jersey Lawmaker to Propose Bill to Treat Recovered COVID-19 Patients No Different Than Vaccinated People
    New Jersey state Sen. Joe Pennacchio announced on Wednesday he would introduce new legislation that would treat recovered ...
    September 16, 2021BY Ella Kietlinska
  • Mayo Study Finds Antibody Treatment Can Help COVID-19 Patients
    Mayo Study Finds Antibody Treatment Can Help COVID-19 Patients
    By Christopher Snowbeck From Star Tribune MINNEAPOLIS—A subset of COVID-19 patients who received infusions of laboratory-made antibodies ran ...
    September 1, 2021BY Tribune News Service
  • Why Is COVID-19 Severe for Some?
    Why Is COVID-19 Severe for Some?
    Are the antibodies we produce to fight COVID-19 infection causing severe disease? A new paper—so new in fact ...
    August 31, 2021BY Jennifer Margulis
  • President Tsai First Taiwanese to Get Locally-Made Vaccine
    President Tsai First Taiwanese to Get Locally-Made Vaccine
    Taiwanese President Tsai Ing-wen received her first dose of the island's domestically developed CCP (Chinese Communist Party) virus, ...
    August 23, 2021BY The Associated Press
  • UK’s Regulator Approves First Drug Designed Specifically to Tackle COVID-19
    UK’s Regulator Approves First Drug Designed Specifically to Tackle COVID-19
    The medicines regulator has approved use of the first treatment in the UK using man-made antibodies to prevent ...
    August 20, 2021BY PA Media
  • Shouldn’t Natural Immunity Earn Some Freedom?
    Shouldn’t Natural Immunity Earn Some Freedom?
    Millions have rolled up their sleeves to take the COVID-19 vaccination because the jab promises protection against the ...
    April 22, 2021BY Conan Milner
  • Half of People in UK Have CCP Virus Antibodies: ONS Data
    Half of People in UK Have CCP Virus Antibodies: ONS Data
    Half of Brits are now likely have antibodies to the CCP virus—from either natural immune response or from ...
    March 31, 2021BY Simon Veazey
  • UCI Reduces COVID-19 Hospitalizations Through Transfusions 
    UCI Reduces COVID-19 Hospitalizations Through Transfusions 
    The University of California–Irvine (UCI) says it’s found a way to reduce COVID-19 related hospitalizations, and the strategy ...
    February 9, 2021BY Jack Bradley
  • 1 in 7 Had CCP Virus Antibodies in England in January: Report
    1 in 7 Had CCP Virus Antibodies in England in January: Report
    An estimated 1 in 7 people had antibodies to the CCP virus in England in January, according to an analysis of a ...
    February 3, 2021BY Simon Veazey
  • 1 in 8 People in England Had Antibodies to CCP Virus in December: Report
    1 in 8 People in England Had Antibodies to CCP Virus in December: Report
    An estimated one in eight people had antibodies to the CCP virus in England in December, according to ...
    January 19, 2021BY Simon Veazey
TOP NEWS
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    NEW By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    2hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    3hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing–How to Enhance Its Function
    3hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing–How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    7hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    8hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    9hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
  • Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
    14hr By Melanie Sun
    Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
  • Kentucky Derby Champion Golden Tempo Wins 2026 Belmont Stakes
    16hr By Ross Kelly
    Kentucky Derby Champion Golden Tempo Wins 2026 Belmont Stakes
  • Hegseth Warns Europe of ‘Dangerous Ideologies’
    17hr By Tom Gantert
    Hegseth Warns Europe of ‘Dangerous Ideologies’
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top